December 30, 2010
Bookmark and Share  
 
  HCV
»
»
»
»

 

Hello

This week’s Eblast features the following items:

    • The Top Ten News Items of 2010 – a compilation of what we believed were the top ten stories of 2010.  We judged telaprevir and boceprevir as the number one new story(s) of 2010, but the other items are in no particular order.  We would like to hear from our web site audience about what they believe are the top stories—take a very brief one page survey .

    • This month’s “HCV Snapshots” include recaps of studies on optimizing ribavirin dose, predictors of early treatment discontinuation and its effect on SVR, HCV transmission in colonoscopy centers, and much more.

    • Read about the latest information on Vitamin D in this month’s “HealthWise” column.

    • “AASLD 2010 – Part 2” includes a recap of some interesting data from the IDEAL study, the latest on treatment and improvements in liver health, and data about PEG LAMBDA, a new and different type of interferon being tested to treat HCV.

  • Top Ten News Stories about Hepatitis B—read about the news items that Christine Kukka, HBV Project Manager, ranked as the top news stories about HBV in 2010. .  We would like to hear from our web site audience about what they believe are the top stories—take a very brief one page survey.

  • HBV Journal Review: The state of HBV screening or not; new ways to detect and prevent liver cancer; new discoveries about tenofovir; telbivudine safety, and more.

  • Our guide for those newly diagnosed – First Steps with Hepatitis C for the Newly Diagnosed – has been updated with the latest information and a new look. 

 

 

Sincerely,
Alan

 

Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org

.

**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org

**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.

.

  HBV
»
»
»